For instance, if incretin-based drugs are significantly associated with an increased risk of ICC but not ECC and GBC, then studies that include more ICC cases are likely to conclude that incretin-based drugs are associated with an increased risk of BTC, and at one extreme, all BTC included are ICC. The gene discussed is GCG; the disease is intrahepatic cholangiocarcinoma.